52 Results for "

GIPR

" in MedChemExpress (MCE) Product Catalog:
Products (52)

52 Results for "GIPR" in MCE Product Catalog:

Cat. No.: HY-P703685
Purity:  ≥ 95%, as determined by reducing Bis-Tris PAGE.
Synonyms: GIPR; GIP-R; Gastric Inhibitory Polypeptide Receptor; PGQTL2; Glucose-Dependent Insulinotropic Polypeptide Receptor
Species:  
Cynomolgus
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-181709
Synonyms: TG062
TPM003 (TG062) is a triple agonist of GLP-1R, GIPR and GCGR, with EC50 values of 33.9, 12.5 and 92.9 pM, respectively. TPM003 suppresses appetite, regulates blood glucose, enhances insulin sensitivity, reduces gastrointestinal intolerance, promotes hepatic lipid mobilization and increases energy expenditure. TPM003 induces weight loss, improves metabolic parameters, reverses hepatic steatosis and optimizes liver function markers. TPM003 is applicable for research on obesity and non-alcoholic steatohepatitis .
loading...
    loading...
Cat. No.: HY-P0276F
Research Areas:  

Others

GIP, Cy5 labeled TFA is a Cy5-labeled gastric inhibitory polypeptide (GIP), which is specifically used to label endogenously/exogenously expressed glucose-dependent insulinotropic polypeptide receptor (GIPR) .
loading...
    loading...
Cat. No.: HY-P12137
CAS No.: 2869056-74-4
Synonyms: RAY1225
Research Areas:  

Metabolic Disease

Bilpatide (RAY1225) is a dual agonist of glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR). Bilpatide is applicable to research related to obesity and diabetes .
loading...
    loading...
Cat. No.: HY-P3506S
Synonyms: LY3437943, Pro40(13C5,15N) TFA
Retatrutide, Pro40( 13C5, 15N) (LY3437943, Pro40( 13C5, 15N) TFA) is the 13C, 15N-labeled Retatrutide (HY-P3506). Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity .
loading...
    loading...
Cat. No.: HY-P3506S1
Synonyms: LY3437943, Phe22(13C9,15N) TFA
Retatrutide, Phe22( 13C9, 15N) (LY3437943, Phe22( 13C9, 15N) TFA is the 13C, 15N-labeled Retatrutide (HY-P3506). Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity .
loading...
    loading...
Cat. No.: HY-P11672
CAS No.: 3058127-20-8
Synonyms: HDM1005
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Poterepatide (HDM1005) is a long-acting GLP-1R/GIPR peptide dual agonist. Poterepatide exhibits potent activity on both GLP-1 and GIP receptors. Poterepatide can be used for the study of obesity and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P11487
Target:  

GLP Receptor GCGR

UTG-4 is a GLP-1R, GIPR, and GCGR agonist with EC50 values of 126.3 pM, 29.2 pM, and 250.2 pM, respectively. UTG-4 binds to HSA (Kd = 14.6 μM). UTG-4 effectively alleviates endothelial-mesenchymal transition. UTG-4 promotes weight loss, inhibits food intake, improves glucose tolerance, and has a significant anti-atherosclerotic effect .
loading...
    loading...
Cat. No.: HY-182580
CAS No.: 1942922-78-2
HBK001 is an orally active and selective dual GPR119 agonist and DPP-IV inhibitor. HBK001 triggers cAMP production, PKA activation, CREB phosphorylation, glucose-stimulated insulin secretion, plasma incretin elevation, β-cell proliferation, and β-cell function gene up-regulation. HBK001 reduces blood glucose, ameliorates hyperglycemia, improves glucose tolerance, and enhances islet morphology. HBK001 can be used for the research of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-P11880
Target:  

GCGR

Research Areas:  

Metabolic Disease

LY3324954 is a long-acting, highly selective glucagon receptor (GCGR) agonist. LY3324954 stimulates cAMP production via the hepatic GCGR signaling pathway and induces acute blood glucose elevation, while promoting FGF21 expression in the liver and plasma. LY3324954 reduces body weight and abdominal fat mass, increases energy expenditure, and effectively improves lipid homeostasis, insulin sensitivity, and glucose intolerance. LY3324954 can be used in obesity-related research .
loading...
    loading...
Cat. No.: HY-189219
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

GLP-1R modulator-3 is an orally active positive allosteric modulator of GLP-1R, with a Kd of 11.4 μM. GLP-1R modulator-3 exhibits no intrinsic GLP-1R agonistic activity. GLP-1R modulator-3 exerts a hypoglycemic effect in hGLP-1R knock-in mice. GLP-1R modulator-3 is applicable for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P12141
CAS No.: 2227651-65-0
Synonyms: KP405
DA5-CH (KP405) is a blood-brain barrier-permeable GLP-1/GIP receptor agonist. DA5-CH activates GLP-1 and GIP receptors, inhibits the NF-κB inflammatory pathway, reduces α-synuclein (α-synuclein) levels, restores the expression of tyrosine hydroxylase and neurotrophic factors, improves motor function, decreases amyloid plaques and phosphorylated tau protein levels in the hippocampus, restores synaptic plasticity, regulates the PI3K/AKT/GSK3β and CREB signaling pathways, and alleviates mitochondrial stress. DA5-CH can be used for research on Parkinson's disease and Alzheimer's disease .
loading...
    loading...